Hypothetical Case of Transitory Ischemic Attack
Abstract
<div> <p><strong>Hypothetical Case of Transitory Ischemic Attack</strong></p> <p>Student Name</p> <p>Institutional Affiliation</p> <p>Instructor's Name</p> <p>Course</p> <p>Date</p> <h2>Clinical Presentation and Initial Patient Assessment</h2> <h3>Chief Complaint</h3> <p>The patient complained of dizziness, speaking difficulty, weakness in the right hand, and loss of balance for three hours before returning to normal.</p> <h3>History of Present Illness</h3> <p>A 55-year-old Hispanic male arrived at the clinic reporting that he felt well overall but had experienced dizziness, difficulty speaking, a severe headache, loss of balance, and weakness in his right hand for approximately three hours. The patient stated that the symptoms developed suddenly and denied any recent physical or emotional trauma. He reported that he had never previously experienced these symptoms and denied fever, chills, fatigue, and nausea.</p> <p>The patient explained that when attempting to speak, he had difficulty producing words and was unable to raise his right hand or grasp objects effectively. He also reported difficulty walking because of dizziness, headache, and impaired balance. Eventually, he sat down because of the severity of the symptoms. He attempted to continue speaking but found communication difficult. All symptoms resolved within approximately three hours.</p> <p>The patient appeared obese and reported a history of smoking and alcohol use. He also reported a history of hypertension and hypercholesterolemia and stated that he was currently taking prescribed medications.</p> <h2>Medical History and Current Health Status Evaluation</h2> <h3>Past Medical History</h3> <p>The patient reported a history of hypertension and high cholesterol diagnosed approximately two years earlier.</p> <h3>Surgical History</h3> <p>Right inguinal hernia repair surgery in 2018.</p> <h3>Current Medications</h3> <p>Lisinopril/Hydrochlorothiazide 20/25 mg daily, Bystolic 5 mg daily, Aspirin 325 mg daily, Plavix 75 mg daily, and Lipitor 40 mg daily.</p> <h3>Allergies</h3> <p>Allergic to pollen grains and cereals.</p> <h3>Blood Transfusion History</h3> <p>The patient reported no history of blood transfusions.</p> <h3>Screening and Vital Signs</h3> <p>Objective findings included a pulse rate of 106 beats per minute, blood pressure of 134/84 mmHg, temperature of 97.9°F, weight of 195 pounds, height of 5 feet 5 inches, and a body mass index of 32 kg/m².</p> <h2>Comprehensive Review of Systems Findings</h2> <p><strong>General:</strong> Denied fever, chills, fatigue, night sweats, abnormal energy levels, or sudden weight changes.</p> <p><strong>Respiratory:</strong> Denied dyspnea, wheezing, or productive and nonproductive cough.</p> <p><strong>Skin:</strong> Denied edema, discoloration, mole changes, rashes, lesions, pimples, or open wounds.</p> <p><strong>Cardiovascular:</strong> Denied palpitations, edema, orthopnea, and chest pain.</p> <p><strong>HEENT:</strong> Denied scalp abnormalities, visual disturbances, eye pain, hearing loss, ear drainage, nasal congestion, epistaxis, sore throat, hoarseness, dysphagia, and oral lesions. Reported speech difficulties.</p> <p><strong>Neurological:</strong> Reported difficulty speaking, right-hand weakness, tremors, dizziness, and balance problems.</p> <p><strong>Musculoskeletal:</strong> Reported right-hand numbness and gait instability. Denied severe back pain, muscle pain, joint pain, or swelling.</p> <p><strong>Hematologic/Lymphatic/Endocrine:</strong> Denied abnormal thirst, appetite changes, fatigue, and swollen lymph nodes.</p> <p><strong>Psychiatric:</strong> Denied significant anxiety, emotional distress, or excessive fear.</p> <h2>Physical Examination Findings Supporting Neurological Evaluation</h2> <p>The patient appeared overweight but in no acute distress. He was appropriately dressed and cooperative throughout the examination. Pupils were equal, round, and reactive to light and accommodation. Extraocular movements were intact. Ear canals were patent and free of lesions, and tympanic membrane landmarks were visible bilaterally.</p> <p>The nasal mucosa appeared pink and healthy, with no evidence of septal deviation. Oral mucosa was pink without lesions, and dentition was in good condition. The thyroid gland was normal in size and consistency. The patient demonstrated full range of motion of both upper and lower extremities without pain, tenderness, or stiffness. He remained alert, attentive, and appropriately responsive during questioning.</p> <h2>Evidence-Based Diagnosis of Transient Ischemic Attack</h2> <h3>Primary Diagnosis</h3> <p><strong>G45.9 – Transient Ischemic Attack (TIA)</strong></p> <p>Transient Ischemic Attack, commonly referred to as a mini-stroke, occurs when blood flow to part of the brain is temporarily reduced. Unlike major strokes, TIAs generally do not result in permanent neurological deficits. Common symptoms include dizziness, balance disturbances, numbness, weakness, speech difficulties, severe headaches, vision changes, and transient neurological impairment (Abdulkarim et al., 2021).</p> <p>The patient reported several symptoms strongly associated with TIA, including sudden onset dizziness, speech impairment, right-hand weakness, balance problems, and severe headache. The symptoms resolved completely within three hours, which is characteristic of transient ischemic events. Additional risk factors supporting the diagnosis include obesity, smoking history, hypertension, hypercholesterolemia, and evidence of atrial fibrillation on electrocardiogram testing.</p> <p>The positive diffusion findings on brain MRI further support a cerebrovascular etiology. Based on the patient's presentation, risk factors, and diagnostic findings, TIA represents the most appropriate primary diagnosis.</p> <h2>Differential Diagnostic Considerations and Exclusion Criteria</h2> <h3>E16.2 – Hypoglycemia</h3> <p>Hypoglycemia occurs when blood glucose levels fall below normal ranges. Common manifestations include anxiety, palpitations, tremors, fatigue, hunger, sweating, irritability, and instability. Although the patient reported dizziness and weakness, the overall clinical presentation was more consistent with focal neurological dysfunction than metabolic disturbance. Diagnostic testing and clinical findings reduced the likelihood of hypoglycemia as the primary diagnosis.</p> <h3>R56.9 – Postictal (Todd's) Paralysis</h3> <p>Todd's paralysis is a transient neurological deficit that occurs following seizure activity. Common symptoms include weakness, speech disturbances, confusion, and temporary paralysis (Xu et al., 2020). The patient denied any history of epilepsy or seizure activity. Furthermore, the absence of witnessed seizure events and supporting clinical findings makes this diagnosis less likely.</p> <h3>G43.109 – Complex Migraine</h3> <p>Complex migraines may present with neurological symptoms including headaches, visual disturbances, sensory changes, and speech difficulties. Although the patient reported a severe headache, he denied symptoms commonly associated with migraines such as photophobia, phonophobia, and recurrent headache history. The patient's vascular risk factors and MRI findings further support a cerebrovascular rather than migraine-related cause.</p> <h2>Treatment and Secondary Prevention Strategy</h2> <h3>Pharmacological Management</h3> <p>The patient was prescribed Aspirin 50 mg orally once daily and Atorvastatin 40 mg orally once daily as part of secondary stroke prevention measures (Lan et al., 2020).</p> <h3>Diagnostic Studies</h3> <p>Blood glucose: 58 mg/dL.</p> <p>Prothrombin time, INR, and activated partial thromboplastin time: Normal.</p> <p>Chemistry profile: Normal.</p> <p>Complete blood count: Normal.</p> <p>Electrocardiogram: Atrial fibrillation present.</p> <p>Brain MRI: Positive diffusion-weighted imaging findings.</p> <h3>Lifestyle and Risk Factor Modification</h3> <p>The patient was counseled regarding smoking cessation, alcohol moderation, weight reduction, regular physical activity, and adherence to a heart-healthy diet. These interventions are essential for reducing future cerebrovascular risk.</p> <h3>Non-Pharmacological Interventions</h3> <p>No additional non-pharmacological interventions were initiated at the current visit.</p> <h3>Referral Considerations</h3> <p>No referrals were initiated during this encounter.</p> <h2>Follow-Up and Ongoing Monitoring Recommendations</h2> <p>The patient was instructed to return immediately if neurological symptoms recur or if medication-related adverse effects develop. Routine follow-up appointments should focus on monitoring blood pressure, cholesterol management, medication adherence, weight control, and stroke risk reduction. Continued evaluation of atrial fibrillation and cardiovascular risk factors is recommended to prevent future cerebrovascular events.</p> </div>